🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users injecting products of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Service Response and Content Removal

According to TikTok, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.

After moments of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Costs

Within these groups, posts display dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially serious health risks”.